Alliance Pharma (FRA:DVL) Other Net Income (Loss) : €0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Alliance Pharma Other Net Income (Loss)?

Alliance Pharma's Other Net Income (Loss) for the six months ended in Dec. 2024 was €0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.0 Mil.

Alliance Pharma's quarterly Other Net Income (Loss) declined from Dec. 2023 (€0.0 Mil) to Jun. 2024 (€-0.0 Mil) but then increased from Jun. 2024 (€-0.0 Mil) to Dec. 2024 (€0.0 Mil).

Alliance Pharma's annual Other Net Income (Loss) increased from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil) but then declined from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil).

Alliance Pharma Other Net Income (Loss) Historical Data

The historical data trend for Alliance Pharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Other Net Income (Loss) Chart

Alliance Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Alliance Pharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Alliance Pharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Alliance Pharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (FRA:DVL) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

APH:UK

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. The company generates the majority of its revenue from the Consumer Healthcare segment. The products of the company include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, Fazol, and others. Geographically, the company derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Alliance Pharma Headlines

No Headlines